NASDAQ:IFRX - InflaRx N.V.
$2.64
 $0.00
0.00%
4:00PM EDT
2019-08-20
Inflarx NV, formerly Fireman BV, is a holding company for InflaRx GmbH, a Germany-based clinical-stage biopharmaceutical company. The Company's primary focus is on the development of monoclonal antibodies targeting activation products of the complement system for application in the treatment of life-threatening inflammatory diseases. Its lead product candidate, IFX-1, is an intravenously delivered first-in-class anti-C5a monoclonal antibody, undergoing Phase II clinical trial for the treatment of Hidradenitis Suppurativa (HS), a rare and chronic debilitating systemic inflammatory skin disease, and entering Phase II clinical trial for the treatment of ANCA-associated vasculitis (AAV) and other rare autoimmune diseases. The Company's product pipeline also includes IFX-2, which is in preclinical development. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  IFRX     avg for
industry  
  avg for
sector  
42 stocks weight:  16. 31   0. 00   0. 00  
42 stocks rank:  3. 76 K 1. 09 K 744. 02  
# analyst opinions:  6. 00   12. 93   13. 32  
mean recommendation:  3. 20   2. 12   2. 09  

quick ratio:  10. 48   5. 33   1. 98  
current ratio:  10. 67   5. 72   2. 51  

target price low:  4. 00   79. 69   111. 65  
target price avg:  4. 67   100. 92   134. 03  
target price high:  6. 00   127. 65   152. 12  
1-yr high:  51. 61   105. 44   137. 25  
last close:  2. 64   78. 87   118. 71  
50-day avg:  3. 04   80. 14   119. 68  
200-day avg:  27. 71   82. 14   115. 94  
1-yr low:  2. 56   63. 16   95. 70  
volume:  569. 74 K 3. 02 M 3. 62 M
50-day avg volume:  1. 17 M 3. 81 M 4. 30 M
200-day avg volume:  689. 06 K 3. 21 M 4. 76 M

1-day return:  0. 00 % -0. 77 % -0. 66 %
this week return:  0. 38 % 0. 77 % 0. 25 %
12-wk return:  -92. 66 % 4. 28 % 6. 91 %
52-wk return:  -91. 40 % -2. 11 % 5. 10 %

enterprise value (EV):  68. 29 M 43. 01 B 112. 68 B
market cap:  68. 55 M 502. 93 B 4. 75 T
debt/equity:  0. 75   242. 17   143. 07  

shares outstanding:  23. 81 M 568. 69 M 1. 26 B
shares:  16. 33 M 578. 73 M 1. 20 B
shares short:  1. 57 M 15. 55 M 13. 59 M
shares short prior month:  1. 24 M 11. 65 M 12. 17 M
short ratio:  1. 18   6. 99   4. 01  
short % of float:  7. 81 % 7. 00 % 2. 78 %

book value:  7. 20   13. 06   26. 70  
price/book:  0. 37   -1. 46   7. 03  
operating margins:  0. 00 % -527. 13 % -123. 82 %
EBITDA margins:  0. 00 % 7. 02 % 24. 14 %
profit margins:  0. 00 % 2. 80 % 14. 63 %
gross margins:  0. 00 % 39. 64 % 57. 79 %

1-yr max volatility:  0. 00 % --- ---
1-yr mean volatility:  0. 00 % 1. 25 % 0. 73 %

1-yr EPS:  -1. 39   1. 29   4. 14  
forward EPS:  -2. 15   3. 32   6. 75  
P/E:  -1. 90   15. 80   23. 34  
forward P/E:  -1. 23   4. 74   18. 22  
PE/G:  0. 08   1. 14   -1. 53  
growth:  -24. 83 % 237. 37 % 108. 53 %
earnings high:  -0. 37   1. 18   1. 64  
earnings avg:  -0. 56   0. 82   1. 51  
earnings low:  -0. 71   0. 53   1. 41  
revenue high:  -0. 00   2. 85 B 8. 85 B
revenue avg:  -0. 00   2. 76 B 8. 68 B
revenue low:  -0. 00   2. 69 B 8. 51 B
return on assets:  -19. 37 % -2. 62 % 5. 63 %
return on equity:  -28. 81 % -25. 81 % 21. 08 %

beta (1yr vs S&P500):  0. 67   1. 22   0. 89  
sharpe (1yr):  -0. 61   0. 18   0. 51  

held % insiders:  38. 72 % 6. 61 % 3. 49 %
held % institutions:  60. 93 % 76. 64 % 68. 97 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-08-20 : IFRX
.    101.362 =         101.362 :: --> INITIAL WEIGHT <--
.    - 1.387 =          99.975 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 1.891 =         189.036 :: P/E factor
.    x 1.901 =         359.264 :: PE/G factor
.     x 1.76 =          632.44 :: beta factor
.    x 0.946 =         598.059 :: sharpe factor
.    x 1.182 =         706.703 :: current ratio factor
.    x 0.874 =         617.792 :: quick ratio factor
.    x 1.461 =         902.806 :: short ratio factor
.    x 1.002 =          904.46 :: price-to-book factor
.    x 2.291 =        2072.284 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.715 =        5626.804 :: sector+industry 1-year gains factor
.    x 1.043 =        5867.436 :: industry 12-weeks return factor
.    x 1.312 =        7697.145 :: industry 2-weeks return factor
.    x 0.993 =        7643.032 :: "drift" penalty 1 days ago
.    x 0.999 =        7635.041 :: "drift" penalty 3 days ago
.    x 0.929 =        7091.688 :: overall "drift" factor
.    x 0.942 =        6678.061 :: largest single-day price delta factor
.    x 0.069 =         459.289 :: low price factor
.    x 0.047 =          21.521 :: notable returns + performance factor
.                               --> PROJECTIONS <--
.    x 1.369 =          29.467 :: forward P/E factor
.    x 1.182 =           34.84 :: industry recommendation factor
.    x 1.018 =          35.482 :: factor historical industry gain for week 33
.    x 1.891 =          67.079 :: target low factor
.    x 1.292 =          86.686 :: target mean factor
.    x 1.047 =          90.794 :: target high factor
.    x 7.719 =         700.792 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =           5.145 :: reduced for readability
.   + 11.164 =           16.31 :: add/subtract for investor sentiment
.                               --> FINAL WEIGHT <--
.                      16.31 :: FINAL WEIGHT for NASDAQ:IFRX


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org